RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients
Stock Information for Redhill Biopharma Ltd.
Loading
Please wait while we load your information from QuoteMedia.